Optimization of the treatment of anxiety disorders with selank
Comparison in people · 2015
- What was studied
- 70 patients: 40 Selank plus phenazepam; 30 phenazepam alone
- Main finding
- The authors report earlier symptom improvement and fewer unwanted effects with adjunctive Selank. Both groups received phenazepam.
Reported findings and study design
70 patients: phenazepam alone 30 versus phenazepam plus Selank 40.
Population or model 70 patients: 40 Selank plus phenazepam; 30 phenazepam alone
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Anxiety improvement | Earlier with add-on Selank | No numerical magnitude reported |
| Sedation and other adverse symptoms | Fewer reported with the combination | Event counts not supplied |
Both groups received phenazepam. This comparison does not isolate Selank monotherapy.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Does not isolate Selank monotherapy.
- Allocation and blinding unresolved; a combination comparison is not general evidence of safety.
Source details
Journal article
Indexed abstract checked; allocation, blinding and full outcome tables not reviewed.
Abstract
Sources checked
Citation
V. E. Medvedev, O. N. Tereshchenko, N. V. Kost, A. Y. Ter-Israelyan, E. V. Gushanskaya, I. K. Chobanu, O. Y. Sokolov, N. F. Myasoedov. Optimization of the treatment of anxiety disorders with selank Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):33–40
Study source ↗ · DOI 10.17116/jnevro20151156133-40 · Bibliography entry · Link to this summary